Internacional
The FDA is about to decide which peptides could soon become widely available in the U.S. Here's what happens next.
The FDA is deciding whether seven peptides like BPC-157 and TB-500 can be legally compounded, potentially opening the door to broader use in Americans.
Por Redacción Sinergia Empresarial · 23 de julio de 2026 · 1 min
The FDA is deciding whether seven peptides like BPC-157 and TB-500 can be legally compounded, potentially opening the door to broader use in Americans.
Sinergia Empresarial continuará el seguimiento de esta información sobre the FDA is about to decide which peptides could soon become widely available in the U.S. Here's what happens next y ampliará la cobertura conforme se confirmen nuevos elementos relevantes para el ecosistema empresarial.
